Flow Cytometry: Recent Advances in Diagnosis and Monitoring of Leukemia

References

• Drexler H G. Classification of acute myeloid leukemias: A comparison of FAB and immunophenotyping. Leukemia 1987; 1: 697–705
   PubMed Web of Science ®Google Scholar
• Foon K A, Todd R F. Immunologic classification of leukemias and lymphoma. Blood 1986; 68: 1–31
   PubMed Web of Science ®Google Scholar
• Bernard A, Boumsell L, Hill C. Joint Report of the First International Workshop on Human Leucocyte Differentiation Antigens by the investigators of the participating laboratories. Leucocyte Typing, A Bernard, L Boumsell, J Dausset, C Milstein, S F Schlossman. Springer-Verlag, New York 1984; 9–142
   Google Scholar
• Schlossman S F, Boumsell L, Gilks W (1995) Leukocyte Typing V: White Cell Differentiation Antigens. Proceedings of the Fifth International Workshop and Conference. 1995, S F Schlossman, et al. Oxford University Press, Oxford, New York
   Google Scholar
• Drouet M, Lees O. Clinical applications of flow cytometry in hematology and immunology. Biol Cell 1993; 78: 73–78
   PubMed Web of Science ®Google Scholar
• Macy M G. Flow-cytometric analysis of lymphocytes, leukemias and lymphomas. Br J Biomed Sci 1993; 50: 334–349
   PubMed Web of Science ®Google Scholar
• Maeda K, Alessio R C, Hawley R C. Recent advances in diagnosis of leukemia. Jpn J Clin Oncol 1993; 23: 79–84
   PubMed Web of Science ®Google Scholar
• Johnson R L. Flow cytometry: From research to clinical laboratory applications. Clin Lab Med 1993; 13: 831–852
   PubMed Web of Science ®Google Scholar
• Kipps T J, Meisenholder G, Robbins B A. New developments in flow cytometric analyses of lymphocyte markers. Clin Lab Med 1992; 12: 237–275
   PubMed Web of Science ®Google Scholar
• Vaickus L, Ball E D, Foon K A. Immune markers in hematology malignancies. Crit Rev Oncol Hematol 1991; 11: 267–297
   PubMed Web of Science ®Google Scholar
• Foon K A, Robbins B A, Ellison D J, et al. Immunodiagnosis of lymphoid malignancies. Adv Leuk Lymph 1992; 3: 3–11
   Google Scholar
• Borowitz M J. Immunophenotyping of acute leukemia by flow cytometry. Clin Imm Newslett 1993; 13: 53–60
   Google Scholar
• Schumacher H R, Shrit M A, Kowal-Vern A, et al. Acute leukemia and related entities. Impact of new technology. Arch Pathol Lab Med 1991; 115: 331–337
   PubMed Web of Science ®Google Scholar
• Crist W, Shusler J, Look T, et al. Current results of studies of immunophenotype-, age- and leukocyte- based therapy for children with acute lymphoblastic leukemia. Leukemia 1992; 6: 162–166
   PubMed Web of Science ®Google Scholar
• Pui C H, Dodge R K, Look A T, et al. Risk of adverse events in children completeing treatment for actue lymphoblastic leukemia: St. Jude Total therapy studies VIII, IX, and X. J Clin Oncol 1991; 9: 1341–1347
   PubMed Web of Science ®Google Scholar
• Cheson B D, Cassilelh P A, Head D R, et al. Report of the National Cancer Institute-Sponsored Workshop on definitions of Diagnosis and Response in acute myeloid leukemia. J Clin Oncol 1990; 8: 813–319
   PubMed Web of Science ®Google Scholar
• Terstappen L W, Konemann S, Stafford M, et al. Flow cytometric characterization of acute myeloid leukemia. Part I. Significance of light scattering properties. Leukemia 1991; 5: 315–321
   PubMed Web of Science ®Google Scholar
• Harada N, Okamura S, Kubota A, et al. Analysis of acute myeloid leukemia cells by flow cytometry introducing a new light-scattering classification. J Cancer Res Clin Oncol 1994; 120: 553–557
   PubMed Web of Science ®Google Scholar
• Borowitz M J, Guenther K L, Shults K E, et al. Immunophenotyping of acute leukemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate on leukemic balsts in three-color analysis. Am J Clin Pathol 1993; 100: 534–540
   PubMed Web of Science ®Google Scholar
• Betz S A, Foucar K, Head D R, et al. False-positive flow cytometric platelet glycoprotein IIb/IIIa expression in myeloid leukemias secondary to platelet adherence to blasts. Blood 1992; 79: 2399–2403
   PubMed Web of Science ®Google Scholar
• Ivanyi J L, Kiss A, Telek B, et al. Megakaryocyte markers in myeloproliferative disorders. Acta Histochem 1993; 95: 79–88
   PubMed Web of Science ®Google Scholar
• Matolcsy A, Kalman E, Pajor L, et al. Morphologic and flow cytometric analysis of circulating megakaryoblasts in chronic myeloid leukaemia. Leuk Res 1991; 15: 887–897
   PubMed Web of Science ®Google Scholar
• Traweek S T. Immunophenotypic analysis of acute leukemia. Am J Clin Pathol 1993; 99: 504–512
   PubMed Web of Science ®Google Scholar
• Drach D, Drach J, Glassl H, et al. Flow cytometric detection of cytoplasmic antigens in acute leukemias: Implications for lineage assignment. LeukRes 1993; 17: 455–461
   Web of Science ®Google Scholar
• Howell A L, Stukel T A, Bloomfield C D, et al. Predictive value of flow cytometric analyses of blast cells in assessing the phenotype of the leukemia colony-forming cell (L-CFC) population in acute myeloid leukemia. Bone Marrow Transplant 1996; 10: 261–266
   Google Scholar
• Geary W A, Frierson H F, Limes D J. Quantitative criteria for clonality in the diagnosis of B-cell non-Hodgkins lymphoma by flow cytometry. Mod Pathol 1993; 6: 155–161
   PubMed Web of Science ®Google Scholar
• Ligler F S, Smith R G, Kettman J R, et al. Detection of tumor cells in the peripheral blood of nonleukemia patients with B-cell lymphoma: analysis of “clonal excess”. Blood 1980; 55: 792–800
   PubMed Web of Science ®Google Scholar
• Liendo C, Daniev L, Al-Katib A, et al. Phenolypic analysis by flow cytometry of surface immunoglobulin light chains and B and T cell antigens in lymph nodes involved with non-Hodgkins lymphoma. Am J Med 1985; 79: 445–454
   PubMed Web of Science ®Google Scholar
• Batata A, Shen B. Diagnostic value of clonality of surface immunoglobulin light and heavy chains in malignant lymphoproliferative disorders. Am J Hematol 1993; 43: 265–270
   PubMed Web of Science ®Google Scholar
• Foon K A, Rai K R, Gale R P. Chronic lymphocytic leukemia: new insights into biology and therapy. Ami Intern Med 1990; 113: 525–539
   Web of Science ®Google Scholar
• Dorfman D M, Pinkus G S. Distinction between small lymphocytic and mantle cell lymphoma by immunoreactivity for CD23. Mod Pathol 1994; 7: 326–331
   PubMed Web of Science ®Google Scholar
• Harris N L, Jaffe E S, Stein H, et al. A revised European-American classification of lymphoid neoplasms: A proposal from the International lymphoma study group. Blood 1994; 84: 1361–1392
   PubMed Web of Science ®Google Scholar
• Robbins B A, Ellison D J, Spinosa J C, et al. Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia. Blood 1993; 82: 1277–1287
   PubMed Web of Science ®Google Scholar
• Almasri N M, Duque R E, Iturraspe J, et al. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia. Am J Hematol 1992; 40: 259–263
   PubMed Web of Science ®Google Scholar
• Batata A, Shen B. Immunophenotyping of subtypes of B-chronic (mature) lymphoid leukemia. A study of 242 cases. Cancer 1992; 70: 2436–2443
   PubMed Web of Science ®Google Scholar
• Foon K A, Thiruvengadam R, Saven A, et al. Genetic relatedness of lymphoid malignancies: Transformation of chronic lymphocytic leukemia as a model. Ann Intern Med 1993; 119: 63–73
   PubMed Web of Science ®Google Scholar
• Villalona-Calero M, Stewart C, Barcos M, et al. Phenolypic characteristics of “prolymphocytoid” transformed (CLL/PLL) chronic lymphocytic leukemia (CLL) cells. Proc Am Soc Clin Oncol 1991; 10: 230
   Google Scholar
• Banks P M, Chan J, Cleary M L, et al. Mantle cell lymphoma: A proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol 1992; 16: 637–640
   PubMed Web of Science ®Google Scholar
• Geislcr C H, Larsen J K, Hansen N E, et al. Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia. Blood 1991; 78: 1795–1802
   PubMed Web of Science ®Google Scholar
• Amrein P C, Weissman D J, Harris N L, et al. Case records of the Massachusetts General Hospital. Case 43–1994. N Engl J Med 1994; 331: 1576–1582
   PubMedGoogle Scholar
• Juliusson G, Lenkei R, Liliemark J. Flow cytometry of blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells and lymphocyte subsets after treatment with 2-chlorodeoxyadenosine. Blood 1994; 83: 3672–3681
   PubMed Web of Science ®Google Scholar
• Foon K A, Gale R P. Is there a T-cell form of chronic lymphocytic leukemia: Fact or fiction?. Leukemia 1992; 6: 867–868
   PubMed Web of Science ®Google Scholar
• Matutes E, Brilo-Babapulle V, Swansbury J, et al. Clinical and laboratory features of T-prolymphocytic leukemia. Blood 1991; 78: 3269
   PubMed Web of Science ®Google Scholar
• Reynold C W, Foon K A. T gamma-lymphoproliferative disorders in man and experimental animals: A review of the clinical, cellular, and functional characteristics. Blood 1984; 64: 1146
   PubMed Web of Science ®Google Scholar
• Newland A C, Catovsky D, Linch D, et al. Chronic T cell lymphocytosis: A review of 21 cases. Br J Haematol 1984; 58: 433
   PubMed Web of Science ®Google Scholar
• Loughran T P. Clonal diseases of large granular lymphocytes. Blood 1993; 82: 1–14
   PubMed Web of Science ®Google Scholar
• Nichols G E, Normansell D E, Williams M E. Lymphoproliferative disorder of granular lymphocytes: Nine cases including one with features of CD56 (NKHI)-positive aggressive natural killer cell lymphoma. Mod Pathol 1994; 7: 819–824
   PubMed Web of Science ®Google Scholar
• Yalabe Y, Mori N, Hirabayashi N. Natural killer cell leukemia: An autopsy case. Arch Pathol Lab Med 1994; 118: 1201–1204
   PubMed Web of Science ®Google Scholar
• Hanson C A, Abaza M, Sheldon S, et al. Acute biphenotypic leukemia: Immunophenotypic and cytogenetic analysis. Br J Haematol 1993; 84: 49–60
   PubMed Web of Science ®Google Scholar
• Campos L, Guyotal D, Larese A, et al. Expression of CD 19 antigen on acute monoblastic leukemia cells at diagnosis and after TPA-induced differentiation. Leuk Res 1988; 12: 369–372
   PubMed Web of Science ®Google Scholar
• Kita K, Nakase K, Miwa I I, et al. Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: Frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34. Blood 1992; 80: 470–477
   PubMed Web of Science ®Google Scholar
• Hurwitz C A, Raimondi S C, Head D, et al. Distinctive immunophenotypic features of t(8;21) (q22;q22) acute myeloblastic leukemia in children. Blood 1992; 80: 3182–3188
   PubMed Web of Science ®Google Scholar
• Reading C L, Estey E H, Huh Y O, et al. Expression of unusual immunophenotype combinations in acute myelogenous leukemia. Blood 1993; 81: 3083–3090
   PubMed Web of Science ®Google Scholar
• Claxton D F, Reading C L, Nagarajan L, et al. Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocytic leukemia. Blood 1992; 80: 582–586
   PubMed Web of Science ®Google Scholar
• Adriaansen H J, Te Boekhorst P AW, Hagemeijer A M. Acute myeloid leukemia M4 with bone marrow eosinophilia (m4E0) and inv (16) (p13q22) exhibits a specific immunophenotype with CD2 expression. Blood 1993; 81: 3043–3051
   PubMed Web of Science ®Google Scholar
• Paietta E, Wiemik P H, Andersen J, et al. Acute myeloid leukemia m4 with inv (16) (p13q22) exhibits a specific immunophenotype with CD2 expression, correspondence. Blood 1993; 82: 2595
   PubMed Web of Science ®Google Scholar
• Ball E D, David R B, Griffin J D, et al. Prognostic value of lymphocyte surface markers in acute myeloid leukemia. Blood 1991; 77: 2242–2250
   PubMed Web of Science ®Google Scholar
• Kurec A S, Belair P, Stefanu C, et al. Significance of aberrant immunophenotypes in childhood acute lymphoid leukemia. Cancer 1991; 67: 3081–3086
   PubMed Web of Science ®Google Scholar
• Wiersma S R, Ortega J, Sobel E, et al. Clinical importance of myeloid antigen expression in acute lymphoblastic leukemia of childhood. N Engl J Med 1991; 324: 800–808
   PubMed Web of Science ®Google Scholar
• Hayashi Y, Sugita K, Nakazawa S, et al. Karyotypic patterns in acute mixed lineage leukemia. Leukemia 1990; 4: 121–126
   PubMed Web of Science ®Google Scholar
• Sorensen P HB, Chen C S, Smith F O, et al. Molecular rearrangements of the MLL gene are present in most cases of infant acute myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypes. J Clin Invest 1994; 93: 429–437
   PubMed Web of Science ®Google Scholar
• Tritz D, Pettigrew A, Talkington S, et al. Association of CD-15 expression and 11q23 translocation in acute leukemias. Mod Pathol 1995; 8: 122A
   Google Scholar
• Bloomfield C D, Seeker-Walker L M, Goldman Al, et al. Sixth International Workshop on Chromosomes and Leukemias: Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia. Cancer Genet Cytogenet 1989; 40: 171–185
   PubMed Web of Science ®Google Scholar
• Morgan G J, Shiach C, Potter M. The clinical value of detecting gene rearrangements in acute leukemias. Br J Haematol 1994; 88: 459–464
   PubMed Web of Science ®Google Scholar
• Drach J, Drach D, Glassl H, et al. Flow cytometric determination of atypical antigen expression in acute leukemia for the study of minimal residual disease. Cytometry 1992; 13: 893–901
   PubMedGoogle Scholar
• Coustan-Smith E, Behm F G, Hurwitz C A, et al. N-CAM (CD56) expression by CD34+ malignant myeloblasts has implications for minimal residual disease detection in acute myeloid leukemia. Leukemia 1993; 7: 853–858
   PubMed Web of Science ®Google Scholar
• Imamura N, Kuramoto A. Detection of minimal residual disease in acute lymphoblastic leukemia by flow cytometry with monoclonal antibodies. Am J Hematol 1991; 38: 332–334
   PubMed Web of Science ®Google Scholar
• Adriaansen H J, Jacobs B C, Kappers-Klunne M C, et al. Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynculeotidyl transferase and myeloid markers. Leukemia 1993; 7: 472–481
   PubMed Web of Science ®Google Scholar
• Tycko B, Ritz J, Sallan S, et al. Changing antigen receptor gene rearrangements in a case of early pre-B cell leukemia: Evidence for a tumor progenitor cell with stem cell features and implications for monitoring residual disease. Blood 1992; 79: 481–488
   PubMed Web of Science ®Google Scholar
• Vuillier F, Claisse J F, Vandenvelde C, et al. Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical and bone-marrow remission using CD5-CD19 markers and PCR study of gene rearrangements. Leuk Lymphoma 1992; 7: 195–204
   PubMed Web of Science ®Google Scholar
• Giordano M, Danova M, Mazzini G, et al. Cell kinetics with in vivo bromodeoxyuridine assay, proliferating cell nuclear antigen expression, and flow cytometric analysis. Prognostic significance in acute nonlymphoblastic leukemia. Cancer 1993; 71: 2739–2745
   PubMed Web of Science ®Google Scholar
• Hiddemann W, Harbott J, Ludwig W D, et al. DNA aneuploidy in childhood acute lymphoblastic leukemia: relation to clinical determinants and prognosis within four consecutive BFM trials. Rec Results Cancer Res 1993; 131: 113–121
   PubMedGoogle Scholar
• Look A T, Roberson P K, William D L, et al. Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia. Blood 1985; 65: 1079–1086
   PubMed Web of Science ®Google Scholar
• Fujii H, Tanigawa N, Muraoka R, et al. Detection of P-glycoprotein in solid tumors by flow cytometry. Anticancer Res 1993; 13: 2171–2175
   PubMed Web of Science ®Google Scholar
• Hart S M, Ganeshaguru K, Lyttelton M P, et al. Flow cytometric assessment of multidrug resistance (MDR) phenolype in acute myeloid leukaemia. Leuk Lymphoma 1993; 11: 239–248
   PubMed Web of Science ®Google Scholar
• Van Acker K L, Van Hove L M, Boogaerts M A. Evaluation of flow cytometry for multidrug resistance detection in low resistance K562 cells using daunorubicin and monoclonal antibodies. Cytometry 1993; 14: 736–746
   PubMedGoogle Scholar
• Campos L, Rouault J P, Sabido O, et al. High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood 1993; 81: 3091–3096
   PubMed Web of Science ®Google Scholar
• Te Boekhorst P A, De Leeuw K, Schoesler M. Predominance of functional multidrug resistence (MDR-1) phenolype in CD34 + acute myeloid leukemia cells. Blood 1993; 82: 3157–3162
   PubMed Web of Science ®Google Scholar
• Lacombe F, Belloc F, Dumain P, et al. Detection of cytarabine resistance in patients with acute myelogenous leukemia using flow cytometry. Blood 1994; 84: 716–723
   PubMed Web of Science ®Google Scholar
• Moriarty A T, Wiersema L, Snyder W, et al. Immunophenotyping of cytologic specimens by flow cytometry. Diagn Cytopathol 1993; 9: 252–258
   PubMed Web of Science ®Google Scholar
• Zander D S, Iturraspe J A, Everett E T, et al. Flow cytometry, in vitro assessment of its potential application for diagnosis and classification of lymphoid processes in cytologic preparations from fine-needle aspirates. Am J Clin Pathol 1994; 101: 577–586
   PubMed Web of Science ®Google Scholar
• Robins D B, Katz R L, Swan F, et al. Immunotyping of lymphoma by fine-needle aspiration. A comparative study of cytospin preparations and flow cytometry. Am J Clin Pathol 1994; 101: 569–576
   PubMed Web of Science ®Google Scholar
• Kaw Y T, Artymyshyn R L, Schichman S A, et al. Recurrent hairy cell leukemia presenting as a large mesenteric mass diagnosed by fine needle aspiration cytology. A case report. Acta Cytol 1994; 38: 267–270
   PubMed Web of Science ®Google Scholar
• Cline M J. The molecular basis of leukemia. N Engl J Med 1994; 330: 328–336
   PubMed Web of Science ®Google Scholar
• Yano T, Van Krieken J HJM, Magrath I T, et al. Histogenelic correlations between subcategories of small noncleaved cell lymphomas. Blood 1992; 79: 1282–1290
   PubMed Web of Science ®Google Scholar
• Beck J L, Hopman A H, Vooijs G P, et al. Chromosome detection by in situ hybridization in cancer cell populations which were flow cytomelrically sorted after immunolabeling. Cytometry 1992; 13: 346–355
   PubMedGoogle Scholar
• Suijkerbuijk R F, Matthopoulos D, Kearney L, et al. Fluorescent in situ indentification of human marker chromosomes using flow sorting and Alu element-mediated PCR. Genomics 1992; 13: 355–362
   PubMed Web of Science ®Google Scholar
• Lalli E, Gibellini D, Santi S, et al. In situ hybridization in suspension and flow cytometry as a tool for the study of gene expression. Anal Biochem 1992; 207: 298–303
   PubMed Web of Science ®Google Scholar
• Leemhuis T, Leibowitz D, Cox G, et al. Identification of BCR/ABL-negalive primitive hematopoietic progenitor cells within chronic myeloid leukemia marrow. Blood 1993; 81: 801–807
   PubMed Web of Science ®Google Scholar
• Leitenberg D, Rappeport J M, Smith B R. B-cell precursor bone marrow reconstitution after bone marrow transplantation. Am J Clin Pathol 1994; 102: 231–236
   PubMed Web of Science ®Google Scholar
• Davis R E, Longacre T A, Cornbleet P J. Hematogones in the bone marrow of adults. Immunophenolypic features, clinical settings, and differential diagnosis. Am J Clin Pathol 1994; 102: 202–211
   PubMed Web of Science ®Google Scholar
• Richard G, Brody J, Sun T. A case of acute megakaryocytic leukemia with hematogones. Leukemia 1993; 7: 1900–1903
   PubMed Web of Science ®Google Scholar
• Hurwitz C A, Gore S D, Stone K D, et al. Flow cytometric detection of rare normal human marrow cells with immunophenotypes characteristic of acute lymphoblastic leukemia cells. Leukemia 1992; 6: 233–239
   PubMed Web of Science ®Google Scholar
• Waddick K G, Uckun F M. CD5 antigen-positive B lymphocytes in human B cell ontogeny during fetal development and after autologous bone marrow transplantation. Exp Hematol 1993; 21: 791–798
   PubMed Web of Science ®Google Scholar